Physician profile
Jared B Smith
NPI 1710033493
$6,260.63
in general payments reported to CMS, 2019-2025
24 companies · $1,149 in 2025
The $1,149 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $698 · 2020: $2,540 · 2021: $107 · 2022: $672 · 2023: $306 · 2024: $789 · 2025: $1,149.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,618 · Food and Beverage: $626.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,617.64 |
| Food and Beverage | $626.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,410.58 | 2019-2025 | |
| Davol INC. | $1,523.73 | 2019-2025 | Phasix Mesh, Arista Ah Flexitip |
| Organogenesis INC. | $259.87 | 2019-2024 | Puraply |
| Smith+Nephew, INC. | $215.62 | 2019-2024 | Collagenase Santyl, Pico 14 |
| Covidien Lp | $148.81 | 2019 | |
| Aroa Biosurgery Incorporated | $120.01 | 2019-2025 | |
| Misonix INC | $110.18 | 2019 | |
| Tela Bio, INC. | $98.60 | 2024-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex), Ovitex 2s |
| Vertex Pharmaceuticals Incorporated | $52.54 | 2024-2025 | |
| Medline Industries Lp | $35.67 | 2019 | |
| Convatec INC. | $28.65 | 2022 | |
| Merck Sharp & Dohme LLC | $26.42 | 2019-2020 | |
| Abbvie INC. | $23.88 | 2022 | |
| Polynovo North America LLC | $23.44 | 2025 | Novosorb Btm |
| Kerecis Limited | $20.27 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $19.42 | 2025 | Transorb |
| Acera Surgical, INC. | $19.39 | 2021 | |
| Ethicon US, LLC | $19.23 | 2021 | |
| Integra Lifesciences Corporation | $18.76 | 2022 | |
| Solventum Corporation | $18.45 | 2025 | V.A.C. Veraflo, Prevena |
| Melinta Therapeutics, LLC | $18.34 | 2019 | |
| Kci USA, INC. | $17.17 | 2019 | |
| 3m Company | $16.54 | 2019 | |
| Tei Medical INC. | $15.06 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jared Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.